Building Intelligent AI Systems for Pharma That
Accelerate Research, Govern Compliance, and Deliver
Life Sciences Outcomes
PLS Domain-Pillar Model
Map Life Sciences Workflows into AI-Ready Domains
Structure pharma workflows into clear domains, pillars, SME functions, and decision units for scalable AI systems.
PHARMACEUTICAL & LIFE SCIENCES
Research & Discovery
FUNCTIONAL AREAS
-
Life Sciences Research -
Genomics / Proteomics
-
Drug Target ID
-
Pharmacology
-
Preclinical Safety
-
PK/PD
-
Formulation & Stability
-
Translational Sciences
SLM USE CASES
Genomics Interpretation SLM
Target Identification SLM
Preclinical Safety Assessment
API Process Description SLM
Method Validation Summary SLM
Control Strategy SLM
Portfolio Prioritization SLM
Patentability Assessment SLM
Contract Clause Interpretation
SOP Drafting SLM
CAPA Root Cause SLM
Change Impact Assessment SLM
Batch Record Review SLM
Deviation Drafting SLM
Tech Transfer Readiness SLM
RWE Study Design SLM
Statistical Method Selection SLM
Data Pipeline Mapping SLM
PHARMACEUTICAL & LIFE SCIENCES
Clinical Development
FUNCTIONAL AREAS
-
Clinical Ops
-
Study Documentation
-
Registries
-
Clinical Safety
-
Data Management
-
Biostats
-
Medical Writing
SLM USE CASES
PHARMACEUTICAL & LIFE SCIENCES
Chemistry, Mfg., Controls
FUNCTIONAL AREAS
-
Drug Substance
-
Drug Product
-
Analytical Methods
-
Stability
-
Process Validation
-
Control Strategy
-
CMC Quality Systems
SLM USE CASES
Genomics Interpretation SLM
Target Identification SLM
Preclinical Safety Assessment
API Process Description SLM
Method Validation Summary SLM
Control Strategy SLM
Portfolio Prioritization SLM
Patentability Assessment SLM
Contract Clause Interpretation
SOP Drafting SLM
CAPA Root Cause SLM
Change Impact Assessment SLM
Batch Record Review SLM
Deviation Drafting SLM
Tech Transfer Readiness SLM
RWE Study Design SLM
Statistical Method Selection SLM
Data Pipeline Mapping SLM
PHARMACEUTICAL & LIFE SCIENCES
Manufacturing & Supply Chain
FUNCTIONAL AREAS
-
GMP Manufacturing
-
Packaging & Labeling
-
Logistics
-
Supply Chain
-
Tech Transfer
-
Digital Manufacturing
SLM USE CASES
Genomics Interpretation SLM
Target Identification SLM
Preclinical Safety Assessment
API Process Description SLM
Method Validation Summary SLM
Control Strategy SLM
Portfolio Prioritization SLM
Patentability Assessment SLM
Contract Clause Interpretation
SOP Drafting SLM
CAPA Root Cause SLM
Change Impact Assessment SLM
Batch Record Review SLM
Deviation Drafting SLM
Tech Transfer Readiness SLM
RWE Study Design SLM
Statistical Method Selection SLM
Data Pipeline Mapping SLM
PHARMACEUTICAL & LIFE SCIENCES
Regulatory Affairs
FUNCTIONAL AREAS
-
Global Guidelines
-
Submissions
-
Compliance & Inspections
-
Labeling
-
Adv. & Promotion
-
Health Auth. Inter.
-
Post-App Changes
SLM USE CASES
Genomics Interpretation SLM
Target Identification SLM
Preclinical Safety Assessment
API Process Description SLM
Method Validation Summary SLM
Control Strategy SLM
Portfolio Prioritization SLM
Patentability Assessment SLM
Contract Clause Interpretation
SOP Drafting SLM
CAPA Root Cause SLM
Change Impact Assessment SLM
Batch Record Review SLM
Deviation Drafting SLM
Tech Transfer Readiness SLM
RWE Study Design SLM
Statistical Method Selection SLM
Data Pipeline Mapping SLM
PHARMACEUTICAL & LIFE SCIENCES
Quality & Risk Mgmt.
FUNCTIONAL AREAS
-
Quality Systems
-
CAPA
-
Audits
-
Risk Management
-
Advanced Quality Engineering
-
Change Control
SLM USE CASES
Genomics Interpretation SLM
Target Identification SLM
Preclinical Safety Assessment
API Process Description SLM
Method Validation Summary SLM
Control Strategy SLM
Portfolio Prioritization SLM
Patentability Assessment SLM
Contract Clause Interpretation
SOP Drafting SLM
CAPA Root Cause SLM
Change Impact Assessment SLM
Batch Record Review SLM
Deviation Drafting SLM
Tech Transfer Readiness SLM
RWE Study Design SLM
Statistical Method Selection SLM
Data Pipeline Mapping SLM
PHARMACEUTICAL & LIFE SCIENCES
Commercial & Mkt Strategy
FUNCTIONAL AREAS
-
Market Access
-
Pharmacoeconomics
-
Comp. Intelligence
-
Medical Affairs
-
Evidence Synthesis
-
Publications
SLM USE CASES
Genomics Interpretation SLM
Target Identification SLM
Preclinical Safety Assessment
API Process Description SLM
Method Validation Summary SLM
Control Strategy SLM
Portfolio Prioritization SLM
Patentability Assessment SLM
Contract Clause Interpretation
SOP Drafting SLM
CAPA Root Cause SLM
Change Impact Assessment SLM
Batch Record Review SLM
Deviation Drafting SLM
Tech Transfer Readiness SLM
RWE Study Design SLM
Statistical Method Selection SLM
Data Pipeline Mapping SLM
PHARMACEUTICAL & LIFE SCIENCES
Corporate, Legal & Strategy
FUNCTIONAL AREAS
-
Strategy
-
Portfolio Planning
-
Patents & IP
-
Legal
-
HR / Finance / IT
-
PMO
SLM USE CASES
Genomics Interpretation SLM
Target Identification SLM
Preclinical Safety Assessment
API Process Description SLM
Method Validation Summary SLM
Control Strategy SLM
Portfolio Prioritization SLM
Patentability Assessment SLM
Contract Clause Interpretation
SOP Drafting SLM
CAPA Root Cause SLM
Change Impact Assessment SLM
Batch Record Review SLM
Deviation Drafting SLM
Tech Transfer Readiness SLM
RWE Study Design SLM
Statistical Method Selection SLM
Data Pipeline Mapping SLM
PHARMACEUTICAL & LIFE SCIENCES
Analytics & Decisions
FUNCTIONAL AREAS
-
Real-World Evidence (RWE)
-
Model & Simulation
-
Math & Statistics
-
AI/ML
-
Data Engineering
-
Quantitative Sciences
SLM USE CASES
Genomics Interpretation SLM
Target Identification SLM
Preclinical Safety Assessment
API Process Description SLM
Method Validation Summary SLM
Control Strategy SLM
Portfolio Prioritization SLM
Patentability Assessment SLM
Contract Clause Interpretation
SOP Drafting SLM
CAPA Root Cause SLM
Change Impact Assessment SLM
Batch Record Review SLM
Deviation Drafting SLM
Tech Transfer Readiness SLM
RWE Study Design SLM
Statistical Method Selection SLM
Data Pipeline Mapping SLM
PLS Value Areas
Where Pharma AI Creates Decision Advantage
Map life sciences work into governed AI use cases that improve evidence review, compliance readiness, quality decisions, and operational speed.
01
Discovery Intelligence
Interpret genomics, target ID, pharmacology, PK/PD, and preclinical signals to support faster research decisions.
02
Clinical Evidence Review
Structure protocols, study documents, safety data, biostatistics, and medical writing into decision-ready evidence.
03
CMC Decision Support
Assist method validation, stability, process validation, control strategy, and CMC documentation with traceable AI.
04
Quality & CAPA Reasoning
Support SOP drafting, CAPA root cause analysis, audit readiness, risk reviews, and change impact assessment.
05
Regulatory Intelligence
Organize guidelines, submissions, labeling, inspections, HA interactions, and post-approval change workflows.
06
RWE & Analytics Decisions
Enable RWE study design, modeling, simulation, AI/ML, statistical method selection, and data pipeline mapping.
Why Choose TekFrameworks?
Built for Regulated Life Sciences AI
TekFrameworks brings domain structure, governance discipline, and AI execution models designed for high-stakes pharma and life sciences workflows.
Domain-First AI Design
Structure PLS use cases around real pharma functions, from discovery and clinical to CMC, quality, regulatory, and analytics.
SME-Aligned Workflows
Reduce ambiguity in SME inputs, data mapping, and workflow boundaries with a repeatable Domain-Pillar-Function model.
Governance Built In
Embed traceability, audit readiness, compliance checkpoints, and decision ownership into AI workflows from the start.
Decision-Ready Intelligence
Move beyond summaries into evidence-backed outputs for CAPA, submissions, clinical review, RWE, and portfolio decisions.
Scalable AI Architecture
Build reusable AI patterns across functions, enabling domain SLMs, SparLM reasoning, and future Brain Unit expansion.
Testimonials
Life Sciences Teams Turning Complexity into Clarity
Trusted by pharma and life sciences teams to structure research, regulatory, quality, and analytics workflows into governed AI-ready decisions.
TekFrameworks helped us see how AI could support regulated workflows without losing control, traceability, or scientific context.
Their domain-pillar approach gave our teams a clearer way to map discovery, clinical, CMC, and quality workflows into practical AI use cases.
What stood out was the focus on governance. The AI roadmap was not just about automation, but about evidence, accountability, and audit readiness.
TekFrameworks translated complex pharma decision flows into structured AI opportunities across RWE, CAPA, submissions, and portfolio decisions.
FAQ’S
Questions on PLS AI? We’ve Got You Covered.
Clear answers on how TekFrameworks structures pharma and life sciences AI across domains, workflows, governance, and decision use cases.
The PLS model structures pharmaceutical and life sciences work into domains, pillars, SME functions, and decision units for AI-ready execution.
It covers discovery, clinical development, CMC, manufacturing, regulatory affairs, quality, commercial strategy, corporate functions, and analytics.
It reduces ambiguity in data mapping, SME alignment, workflow boundaries, and use-case scoping before AI systems are built or deployed.
Yes. The model is designed to strengthen governance, auditability, traceability, and regulatory readiness across high-stakes pharma processes.
Use cases include CAPA reasoning, deviation drafting, batch review, regulatory summaries, RWE study design, clinical evidence review, and CMC support.
No. It can support pharma, biotech, CROs, life sciences service firms, and enterprises building domain AI for regulated decision workflows.
US Office Address
50 Division Street, Suite 501,
Somerville, NJ 08876, US
- Image
- SKU
- Rating
- Price
- Stock
- Availability
- Add to cart
- Description
- Content
- Weight
- Dimensions
- Additional information